Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy

<b>Background:</b> The aim of the study was to investigate a series of complete blood cell count-based biomarkers of systemic inflammation as predictors of clinical outcomes in patients who underwent first-line chemoimmunotherapy for advanced NSCLC. <b>Methods:</b> Consecutive patients with patholog...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carlo Putzu, Riccardo Serra, Rachele Campus, Giovanni Maria Fadda, Claudio Sini, Andrea Marongiu, Giorgio Carlo Ginesu, Alessandro Giuseppe Fois, Giuseppe Palmieri, Angelo Zinellu, Antonio Cossu, Panagiotis Paliogiannis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-08-01
Colecção:	Current Oncology
Assuntos:	lung cancer chemotherapy immunotherapy NLR MNR biomarkers
Acesso em linha:	https://www.mdpi.com/1718-7729/31/9/367
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!